The Effect of Cold Storage Solutions on Ischemic Injury in Lung Transplantation

NCT00284726 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2023-09-28

No results posted yet for this study

Summary

The purpose of this study is to compare 2 different cold storage solutions, used to preserve donor lungs for lung transplantation, and their effect on cytokine activation related to ischemic reperfusion injury. Primary endpoint is 30 day survival.

Conditions

  • Lung Transplant Recipients

Interventions

DEVICE

Celsior Cold Storage Solution

Sponsors & Collaborators

Principal Investigators

  • John V. Conte, M.D. · Johns Hopkins University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-12-31
Completion
2005-09-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00284726 on ClinicalTrials.gov